New study tests best Follow-Up after surgery for oral cancer
NCT ID NCT07457099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with advanced mouth or throat cancer who had chemotherapy and immunotherapy before surgery. After surgery, they will either get radiation, immunotherapy maintenance, or just be watched. The goal is to see which approach helps them live longer without the cancer coming back. About 85 people will take part at one hospital.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PD-1 inhibitor (immunotherapy) and radiotherapy
- What this could lead to
- If successful, this could help doctors choose the best follow-up treatment after surgery for advanced mouth and throat cancers, potentially improving survival and reducing side effects.
- What could go wrong
- This is a small, early-stage study at one hospital, so results may not apply to everyone. The best approach may still be unclear, and both radiotherapy and immunotherapy have risks like severe side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED ORAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Stomatology, Zhujiang Hospital, Southern Medical University, Haizhu District, Guangzhou, Guangzhou, Guangdong 510282
Guangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug duo aims to shrink oral cancers before surgery
- New combo therapy aims to stop oral cancer from coming back
- New combo therapy offers hope for head and neck cancer patients unable to take standard chemo
- New drug combo aims to boost chemoradiation for head and neck cancer
- Mouth bacteria may predict cancer treatment success